Nair, R <br/><br/>
A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma.  [electronic resource] 

 -  Cancer  Jun 1998 
 - 2282-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0142(19980601)82:11<2282::aid-cncr26>3.0.co;2-p  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--therapeutic use<br/>Doxorubicin--adverse effects<br/>Epirubicin--adverse effects<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Survival Rate